Occupational therapy
What studies of occupational therapy found
At a glance, by condition
Long COVID: C Might help, very uncertain
Based on the strongest evidence, studies with no comparison group (very low certainty): 3 findings, all C.
3 outcomes rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: Occupational therapy might help some people with long COVID, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- Occupational therapy · Long COVID is hereCMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- DLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
Long COVID
Symptoms
Fatigue1 study · 17 people took part in occupational therapy Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (17 in all).
Studies with no comparison group17 in the study · "EME was delivered once a week by a trained OT." seven sessions (individual, five group, individual) plus booster email eight weeks after session 7 · "an individual session lasting 45 - 60 min, followed by five group sessions with a maximum of five participants (each session lasting 90 min). After the group sessions, there was another individual session lasting 45 min.", "EME was delivered once a week by a trained OT." plus "a booster mail sent eight weeks after the seventh session"
Fatigue improved.
The evidence is very uncertain about the effect of occupational therapy on fatigue in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (17 in all)
See the 1 study
-
- People in the study
- 17 in the study
- Dose
- "an individual session lasting 45 - 60 min, followed by five group sessions with a maximum of five participants (each session lasting 90 min). After the group sessions, there was another individual session lasting 45 min.", "EME was delivered once a week by a trained OT." plus "a booster mail sent eight weeks after the seventh session"
- Outcome
- fatigue impact (MFIS) modified fatigue impact scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Daily life and health overall
Daily functioning1 study · 17 people took part in occupational therapy Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (17 in all).
Studies with no comparison group17 in the study · "EME was delivered once a week by a trained OT." seven sessions (individual, five group, individual) plus booster email eight weeks after session 7 · "an individual session lasting 45 - 60 min, followed by five group sessions with a maximum of five participants (each session lasting 90 min). After the group sessions, there was another individual session lasting 45 min.", "EME was delivered once a week by a trained OT." plus "a booster mail sent eight weeks after the seventh session"
Daily functioning improved.
The evidence is very uncertain about the effect of occupational therapy on daily functioning in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (17 in all)
See the 1 study
-
- People in the study
- 17 in the study
- Dose
- "an individual session lasting 45 - 60 min, followed by five group sessions with a maximum of five participants (each session lasting 90 min). After the group sessions, there was another individual session lasting 45 min.", "EME was delivered once a week by a trained OT." plus "a booster mail sent eight weeks after the seventh session"
- Outcome
- perceived competency in performing daily activities (OSA) Occupational Self-Assessment
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Quality of life1 study · 17 people took part in occupational therapy Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (17 in all).
Studies with no comparison group17 in the study · "EME was delivered once a week by a trained OT." seven sessions (individual, five group, individual) plus booster email eight weeks after session 7 · "an individual session lasting 45 - 60 min, followed by five group sessions with a maximum of five participants (each session lasting 90 min). After the group sessions, there was another individual session lasting 45 min.", "EME was delivered once a week by a trained OT." plus "a booster mail sent eight weeks after the seventh session"
Quality of life improved.
The evidence is very uncertain about the effect of occupational therapy on quality of life in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (17 in all)
See the 1 study
-
- People in the study
- 17 in the study
- Dose
- "an individual session lasting 45 - 60 min, followed by five group sessions with a maximum of five participants (each session lasting 90 min). After the group sessions, there was another individual session lasting 45 min.", "EME was delivered once a week by a trained OT." plus "a booster mail sent eight weeks after the seventh session"
- Outcome
- Physical Component Scale (PCS) of the health-related quality of life (SF36) Medical Outcome Study 36-item Short Form Health Survey
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Side effects
Stopping because of side effects1 study
we were unable to systematically assess reasons for study discontinuation in our cohort
Improvement in quality of life and cognitive function in Post-COVID syndrome after online occupational therapy: Results from a randomized controlled pilot study. (2025)
All papers
- Improvement in quality of life and cognitive function in Post-COVID syndrome after online occupational therapy: Results from a randomized controlled pilot study.2025 · randomised trial · 163 randomised · 158 analysed
Summary
This unblinded randomized pilot study tested online occupational therapy (OT) in Post-COVID syndrome. Participants were recruited through an online study platform for people affected by PCS; 163 were recruited and 158 were included in the final analysis (mean age 38 yrs., 86% female). Participants received structured online OT over 12 weeks, either interactive digital sessions or prerecorded videos, planned as 24 standardized sessions of 30 minutes delivered twice weekly; a control group received no intervention. Outcomes were assessed at week 0, 12, and 24 and included study experience, quality of life, cognitive function, occupational performance, and social participation. Study experience was positive or very positive in 83.3% of the interactive group versus 48.1% of the video group (p = 0.001); mean OT experience ratings were 4.2 points and 3.3/5 points. At T2, 32.5% of interactive, 59.0% of video, and 24.1% of control participants were lost to follow-up; an additional 2.5% were lost at T3. Compared with control, the interactive group showed improvements in EQ-5D-3L index (mean difference 0.11, 95% CI [0.05–0.17], p = 0.003), Neuro-QoL (mean difference 3.95, 95% CI [2.04–5.86], p < 0.001), and EQ VAS (mean difference 8.04, 95% CI [2.27–13.80], p = 0.038). For other endpoints, there were no significant differences between groups. Harms were not described, and reasons for discontinuation were not systematically assessed.
- Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study.2022 · compared with another group · 590 started · 242 with outcome data
- Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey.2024 · no comparison group · 852 in the study · 536 with outcome data
Summary
This cross-sectional follow-up survey asked patients with long COVID seen at a post-COVID clinic (PCoCC) about symptoms and treatments. A total of 852 patients were identified; 536 completed the survey. The mean time from COVID-19 infection to survey completion was 23.2 ± 6.4 months. There was no comparison group; patients rated symptoms at the initial clinic visit (baseline, by recall) and at follow-up on a 1-10 scale, and rated whether treatments were helpful. Surveyed treatments included low-dose naltrexone, vagal nerve stimulator, midodrine, fludrocortisone, pyridostigmine, aripiprazole, plasmapheresis, reishi mushroom and nattokinase/serrapeptase; treatment duration was not reported. Overall functioning median improved from 8 (6, 9) at baseline to 5 (3, 8) at follow-up (P < .001); fatigue improved from 8 (7,10) to 6 (3, 8) and brain fog from 8 (6, 9) to 5 (3, 8) (P < .001 for both). All individual symptoms assessed were significantly improved (P < .001). Only 4.5% (24/536) had recovered completely. Helpful ratings included low-dose naltrexone 45/77 (58%), vagal nerve stimulator 18/34 (53%), plasmapheresis 9/9 (100%), midodrine 7/17 (41%), fludrocortisone 8/17 (47%), pyridostigmine 2/3 (67%), aripiprazole 8/17 (47%), reishi mushroom 8/19 (42%) and nattokinase/serrapeptase 5/9 (56%). A minority worsened in overall function and in fatigue, myalgia and orthostasis; counts, side-effect counts, and withdrawals due to harms were not reported.
- Energy Management Education in Persons with Long COVID-Related Fatigue: Insights from Focus Group Results on Occupational Therapy Approach.2024 · no comparison group
Summary
This focus-group study explored experiences of people with long COVID-related fatigue who took part in Energy Management Education (EME), an occupational therapy group program, at the Rehabilitation Center Basel in Switzerland. Six EME participants joined focus group discussions after session 7; five of the six joined an online focus group two months later, and all five EME occupational therapists took part in a focus group. EME started with a first individual session (45 min), followed by five group sessions (90 min each, including a 15 min break; max 5 participants). There was no comparison group and the study was not randomised. Participants reported that EME affected their understanding of fatigue and their strategies for managing it; some saw tangible results such as fewer energy crashes and re-engagement in valued activities. They also identified challenges: the workbook’s portability and need for more tailored content, group sessions being too long for some, a focus on physical energy that did not align with some experiences, and a few individuals not seeing substantial improvements. Three participants found the workbook’s weekly plan impractical or not applicable. After two months, several strategies remained helpful, but there was no further mention of self-training tasks. Occupational therapists found group moderation more challenging than with other client groups and recommended smaller numbers of participants and steady groups. Reported harms were three participants canceling the first focus group on short notice due to health issues and one person not joining the online focus group due to Internet unavailability.
- Outcomes of a Fatigue Management Intervention for People With Post COVID-19 Condition.2024 · no comparison group · 60 with outcome data
Summary
This retrospective analysis examined a pilot occupational therapy fatigue management intervention for people with post COVID-19 condition fatigue. Sixty participants (73% female), median age 50.5 yrs (range, 17-74), with 93% reporting symptoms persisting for 12 wks or longer, completed the intervention. How participants were selected and where they were from were not reported. The intervention components, dose, and duration were not reported. There was no comparison group; self-reported measures of fatigue, well-being, and health status were taken at baseline and repeated at 2 wks after intervention, and baseline and postintervention scores were compared using nonparametric analysis. The abstract reports a statistically significant improvement in fatigue; the p value is not printed in the available text. Results for well-being and health status are not reported in the abstract. No participants who worsened or stopped are reported, and harms, side effects, and withdrawals are not reported. The authors state that findings indicate the potential of occupational therapy fatigue management interventions to enable self-management strategies and reduce the negative impact of fatigue among people with post COVID-19 condition. No limitations are stated in the abstract.
- Occupational therapy-based self-management education in persons with post-COVID-19 condition related fatigue: a feasibility study with a pre-post design.2024 · no comparison group · 17 in the study
Summary
This feasibility study asked whether study procedures for a future trial of Energy Management Education (EME) were workable in adults with post-COVID-19 condition-related fatigue at a rehabilitation centre in Basel, Switzerland. During five months, 17 of 30 eligible EME participants were included. EME was delivered once a week by a trained occupational therapist: an individual session, five group sessions, another individual session, and a booster email eight weeks after session 7. There was no comparison group; outcomes were measured before, after, and at follow-up. At T1 all 17 completed assessments; at T2 13/17 returned them, and 12/17 completed the week-24 online survey. No dropouts occurred during the intervention; adverse events were not reported. Self-efficacy (SEPECSA) increased significantly from baseline to T1 (mean difference 1.731), and 12/17 reached the minimal clinically important difference. Fatigue impact (MFIS) decreased; the baseline-to-T2 difference was statistically significant but did not reach a minimal clinically important difference. Perceived competency in daily activities (OSA) increased significantly from baseline to T2. The SF36 Physical Component Scale increased significantly from T1 to T2; the Mental Component Scale showed no statistically significant changes. The authors state the results lack a control group and note missing documentation of treatment fidelity and other intervention intensity.
- Use of Neuromodulation to Treat Post-COVID Neuropathic Pain: A Case Report.2024 · case report · 1 in the study
Summary
This case report describes one 27-year-old man with bilateral upper-extremity neuropathic pain that began with a severe COVID-19 infection about 2 years before presentation. There was no comparison group; reports are before and after treatment in this one patient. He had occupational therapy and trials of amlodipine, sildenafil, gabapentin, duloxetine, and low-dos naltrexone 4.5 mg daily, and a stellate ganglion block, which he said gave no noticeable benefit. He then received a Nevro device with cervical lead placement. A single lead trial with the tip at the C2/C3 interspace gave excellent relief, with a >70% decrease in baseline pain, improved functionality, and increased ability to participate in physical therapy. At implant, two leads were placed, one at C2/C3 and one staggered at C3. More than 6 months after surgery, he reported a 50% improvement in baseline pain and improved functionality, including lifting weights and repetitive motions; he recovered more quickly from pain flares and was quite pleased with the device. Gabapentin seemed most helpful, but he had dosis-limiting side effects, including lethargy. No harms were reported for the device. The authors state limits of case reports: lack of generalisability, inability to establish cause and effect, retrospective design, and potential for overinterpretation.
- Occupational Therapy for the Long Haul of Post-COVID Syndrome: A Case Report.2021 · case report · 1 in the study
Summary
This case report describes occupational therapy for one person with long COVID who was seen in an outpatient setting. The authors say they used evidence-based practice strategies and describe the evaluation, the treatment approaches, the plan of care and the outcomes. The abstract does not say what the therapy involved, how long it lasted, what was measured or how the person did, and it does not mention side effects, so no results can be recorded from it.
- Depression and brain fog as long-COVID mental health consequences: Difficult, complex and partially successful treatment of a 72-year-old patient-A case report.2023 · combination: given with other treatments · 1 in the study
Summary
This case report describes one 72-year-old female with long COVID after COVID-19 infection, treated in a neurological day hospital and a psychiatric inpatient unit and followed as an outpatient. There was no comparison group. Between June 17 and July 8 2022 she was treated in a neurological day hospital without improvement in her health status. She then received outpatient psychiatric help and antidepressant therapy with sertraline 50 mg per day and mirtazapine 15 mg per day for almost 2 months, without significant improvement in her condition. In the psychiatric inpatient unit, between August 29 and September 23, 2022, she received venlafaxine up to 75 mg per day, trazodone up to 50 mg in the evening, nutritional supplements, enteral feeding, and non-drug therapy (visual art, music, drama, dance and movement therapy, occupational therapy, psychotherapy, physiotherapy). At hospitalization, PHQ-9 was 21 and CGI-S was 6; at discharge PHQ-9 was 8, CGI-S 3, and CGI-I 2. At the last outpatient follow-up visit on 01/5/2023, PHQ-9 was 5, CGI-S 3, and CGI-I 2. Mood, energy, anxiety, and sleep improved, but rapid fatigability, difficulty concentrating, unclear thinking, forgetfulness, and brain fog persisted; weight remained 48 kg with no weight gain, and she remained unable to resume work. Side effects and withdrawals were not reported.
- Cognitive Interventions and Rehabilitation to Address Long-COVID Symptoms: A Systematic Review.2026 · systematic review
Summary
This systematic review examined cognitive interventions and rehabilitation for adults with long COVID symptoms. It included 19 articles identified from MEDLINE, CINAHL, PsycINFO, Cochrane Trials, and Scopus, with a search date of July 25, 2023. The review summarized cognitive training, CBT, neurostimulation, combined neurostimulation and cognitive training, and multicomponent rehabilitation programs. Included studies had different designs; the review itself had no comparison group. In a 100-participant randomized trial, an amygdala and insula retraining program was reported to decrease fatigue and increase energy versus control. A 114-participant randomized trial reported CBT reduced fatigue versus care as usual and favored CBT on secondary measures. A 73-participant pre-post study reported higher cognitive scores in all assessed domains after computerized cognitive training. A 64-participant pre-post program reported 42.8% complete recovery and 68% varying improvement in cognitive function, plus significant improvement on the Barthel Index. A 33-participant program reported improved mood, self-efficacy, and participation but no significant fatigue improvement. A 12-participant program reported that all 12 gained insight and 11 reported increased work-life coping. One case report reported short-term memory decreased 15% to 22%. Stopping and side effects were not reported.
- Return to work with long COVID: a rapid review of support and challenges.2025 · systematic review
Summary
This rapid review examined support for return to work in people with long COVID. Searches were completed in June 2024 across major databases including MEDLINE, Embase, PsycINFO, evidence-based medicine reviews, Web of Science and Google Scholar, and twenty-five studies were included. The review covered non-workplace-based support and workplace-based support. Non-workplace support included a telerehabilitation programme using pacing strategies and occupational therapy, pacing strategies, and a home exercise plan with moderate and intense activities. Workplace support included adjusted work arrangements, flexible hours, working from home, task changes, emotional support, financial support, and vocational integration programmes. The review reported that the telerehabilitation programme reduced the number of participants on medical leave by week eight and increased the number returning to full-time work. Patients who adhered more strictly to pacing strategies had higher recovery rates, defined as ability to return to work. A three-month home exercise plan showed no change in work ability from baseline, and the authors noted no significant WAI improvement following a home exercise plan. The review also described organisational barriers such as lack of understanding of long COVID symptoms, insufficient workplace guidance, and educational gaps among managers, and facilitators such as recognition and validation of long COVID and eligibility for disability benefits. The authors state that the search was limited to English language.
- Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review.2023 · systematic review
Summary
This systematic review asked what psychological interventions have been studied in people with COVID-19 or long COVID-19 and comorbid emotional disorders. Searches were run in WOS, Scopus, PubMed, PsycINFO, Cochrane and CINAHL on June 14, 2023. The review included 43 studies with 2,359 adults; only three studies included long COVID-19 patients. Interventions included CBT and psychotherapy, meditation/yoga/breathwork, trauma work such as EMDR, and other approaches. Some studies had control groups, for example Cengiz (Control = 22; intervention = 22), Kong (control = 13; intervention = 13), and Mahendru (control = 42; experimental = 42); others were pre-post without control. Outcomes included anxiety, depression, stress, insomnia, PTSD, and COVID-19 fears. Findings were mixed. Cengiz reported no statistically significant difference between groups at post assessments (p > 0.050). Mahendru found no significant differences in anxiety (mean control = 1.81, mean intervention = 2.14, p = 0.528) but significant differences in depression and stress. Won reported no significant improvements in PHQ-9 and GAD-7 (p > 0.050), with a significant reduction in PTSD symptoms (p = 0.041). In Alkhamees, 2021, 1 participant dropped out of CBT after the 2nd visit. No side-effect counts were recorded. The authors describe promising results but note important limitations.
- Mapping the occupational therapy process in response to COVID-19 and long COVID: A scoping review.2026 · review
Summary
This scoping review asked what occupational therapy process was reported for people with COVID or long COVID; no ME/CFS was mentioned. Three databases were searched for papers published 2020–2023 in English, Portuguese or Spanish. From 455 texts, 25 studies were selected, spanning children to older adults and settings from intensive care to community and telehealth; inpatient hospital units were most frequent. The review mapped evaluation, intervention and outcomes. Standardised assessments covered occupational history, activity limitations, body functions, cognition and emotional regulation; interventions were educational, compensatory, restorative or acquisitional. Findings were reported study by study; intervention duration was not reported. Jung et al. reported time-use occupational therapy was greater than control for occupational balance, QoL and mental health, p < 0.001. Rodrigues et al. reported experimental and control groups both had less fatigue and anxiety; the experimental group also had more well-being and less shortness of breath, ES small to medium. Trzmiel et al. and Zasadzka et al. reported both groups improved significantly but no difference between groups. Pre–post and cohort reports included less depression with online CBT; less dyspnoea and more QoL/endurance with telerehabilitation; 75% had more function; 86% were discharged from hospital; and 56 of 122 (46%) were fully rehabilitated. Case studies reported better ADL, mobility, strength, problem-solving, sleep, fatigue management or return to work; a case study reported no difference in leisure. No harms were recorded.
- Role of Occupational Therapy for Persons Experiencing Long COVID: A Rapid Review.2026 · review
Summary
This rapid review examined the role of occupational therapy for adults and older adults with long COVID across the healthcare continuum. It included Twenty-one articles. The review reports no comparison group and was not randomised. Reviewed occupational therapy interventions were mainly delivered in rehabilitation settings and included retraining in activities of daily living, cognitive rehabilitation, physical and breathing exercises, patient education, return-to-work planning, and psychosocial support. One included trial randomised 64 participants to two groups (n = 32 in each group) and reported that a telerehabilitation exercise program resulted in greater improvements on perceived physical exertion at rest and after physical activity. In another included study, post-course participants reported 53.9% improved health state, 7.9% no change, 10.5% worse health state, and 22.4% mixed change. In a telerehabilitation cohort of 34 enrolled, 30 completed; 63% still experienced post-exertional malaise, only four participants were able to work full-time, and fatigue and health-related quality of life did not statistically or clinically meaningfully improve. An energy management study of 17 participants found the SF36 mental component showed no significant changes. The authors state limitations including potential to miss articles, most studies from North American and European countries, and that most studies were pilot, feasibility, and case studies that lacked power and were heterogeneous.
- Chronic fatigue syndrome: is there a role for occupational therapy?2004 · review
Summary
This composite review examines chronic fatigue syndrome (CFS) and occupational therapy treatment strategies. It reports no single enrolled sample or comparison group; it describes occupational therapy programs and related studies. Programs used CBT, GET and pacing, or energy conservation. In Cox & Findley (1994), twenty-eight subjects met the 1988 definition for CFS; results indicated a 57% improvement in perceived level of activity six months after discharge, and the authors noted a lack of controls. Cox & Findley (1998) studied 109 subjects; 82% perceived an increase of functional ability, and a poorer prognosis for recovery was noted in patients reporting symptoms for more than five years. A survey of 72 patients included 32 patients diagnosed with CFS alone; gradual improvement in activity levels was perceived over three years at six-month intervals, with three patients returning to work. In Essame et al. (1998), nineteen patients received a multi-disciplinary program, which produced an improvement in 89% of patients in eight weeks; after a one-year follow-up of fourteen patients, all had maintained or improved their median scores and only two patients had not improved or were worse by discharge. Packer et al. (1995) studied two groups of 16 participants and reported a decrease in fatigue severity and impact over six weeks. The review noted high withdrawal rates among problems in the literature, without attributing them to a treatment. The authors state that the studies are limited in number and research methods.